Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children

被引:39
|
作者
Ioannidou, S
Tassios, PT
Kotsovili-Tseleni, A
Foustoukou, M
Legakis, NJ
Vatopoulos, A
机构
[1] P&A Kyriakou Childrens Hosp, Dept Clin Microbiol, Athens, Greece
[2] Univ Athens, Sch Med, Dept Hyg & Epidemiol, Athens, Greece
关键词
viridans streptococci; MLSB resistance; children's oral flora;
D O I
10.1016/S0924-8579(00)00338-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A total of 200 isolates of viridans group streptococci isolated from the oropharynx of healthy Greek children were studied. Vancomycin, rifampicin, fluoroquinolones and dalfopristin/quinupristin were active against all tested isolates. High level resistance to gentamicin was not seen. Intermediate and high-level penicillin resistance was present in 28.5 and 14.5% isolates, respectively. with 41.3% of the latter group, being also resistant to cefotaxime. Resistance rates to other antimicrobials were as follows - erythromycin 38.5%, clarithromycin 33.5%, clindamycin 7.5% and tetracycline 23%. Penicillin resistance occurred more frequently in Streptococcus mitis isolates, while macrolide resistance was more frequent in S. oralis. MLSB resistance phenotype M was dominant (74%) among erythromycin resistant isolates, with phenotypes IR and CR being represented by 6 and 20% of isolates, respectively. (C) 2001 Elsevier Science B.V. and International Society of Chemotherapy All rights reserved.
引用
收藏
页码:195 / 201
页数:7
相关论文
共 50 条
  • [31] Macrolide and Ketolide Resistance in a Catchment of Group C and Group G Hemolytic Streptococci
    Weightman, Nigel
    Hartley, Laura
    Weightman, Jessica
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S65 - S65
  • [32] High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients
    Marron, A
    Carratalà, J
    Alcaide, F
    Fernández-Sevilla, A
    Gudiol, F
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (01) : 87 - 91
  • [33] Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis
    Teng, LJ
    Hsueh, PR
    Chen, YC
    Ho, SW
    Luh, KT
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (06) : 621 - 627
  • [34] Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada
    De Azavedo, JCS
    Yeung, RH
    Bast, DJ
    Duncan, CL
    Borgia, SB
    Low, DE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) : 2144 - 2147
  • [35] Antibiotic resistance in oral commensal streptococci from healthy Mexicans and Cubans:: resistance prevalence does not mirror antibiotic usage
    Díaz-Mejía, JJ
    Carbajal-Saucedo, A
    Amábile-Cuevas, CF
    FEMS MICROBIOLOGY LETTERS, 2002, 217 (02) : 173 - 176
  • [36] Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers
    M. Eisenblätter
    C. Klaus
    M. W. R. Pletz
    H. Orawa
    H. Hahn
    J. Wagner
    H. Lode
    European Journal of Clinical Microbiology & Infectious Diseases, 2008, 27 : 1087 - 1092
  • [37] ANTIBIOTIC-RESISTANCE IN PNEUMOCOCCI AND GROUP A-STREPTOCOCCI
    DIXON, JMS
    LIPINSKI, AE
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1979, 70 (01): : 52 - 52
  • [38] Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers
    Eisenblaetter, M.
    Klaus, C.
    Pletz, M. W. R.
    Orawa, H.
    Hahn, H.
    Wagner, J.
    Lode, H.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2008, 27 (11) : 1087 - 1092
  • [39] Antimicrobial Resistance of Community-acquired Bloodstream Isolates of Viridans Group Streptococci
    R. L. Yap
    L. A. Mermel
    J. Maglio
    Infection, 2006, 34 : 339 - 341
  • [40] Mechanisms of macrolide resistance in clinical group B streptococci isolated in France
    Fitoussi, F
    Loukil, C
    Gros, I
    Clermont, O
    Mariani, P
    Bonacorsi, S
    Le Thomas, I
    Deforche, D
    Bingen, E
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) : 1889 - 1891